(Q34119168)

31 July 2017

1 reference

title

Dopamine mercapturate can augment dopaminergic neurodegeneration (English)

1 reference

31 July 2017

1 reference

1 reference

1

Montine TJ

1 reference

31 July 2017

Amarnath V

2

1 reference

31 July 2017

Picklo MJ

3

1 reference

31 July 2017

Sidell KR

4

1 reference

31 July 2017

Zhang J

5

1 reference

31 July 2017

Graham DG

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

31 July 2017

published in

Drug Metabolism Reviews

1 reference

31 July 2017

volume

32

1 reference

31 July 2017

issue

3-4

1 reference

31 July 2017

page(s)

363-376

1 reference

Parkinson's disease. First of two parts

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Oxidative stress, glutamate, and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Glutathione peroxidase, glial cells and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Reactive oxygen species and the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Fibroblasts that express aromatic amino acid decarboxylase have increased sensitivity to the synergistic cytotoxicity of L-dopa and manganese

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Synthesis, redox properties, in vivo formation, and neurobehavioral effects of N-acetylcysteinyl conjugates of dopamine: possible metabolites of relevance to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Toxicology of quinone-thioethers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Quinone chemistry and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

In vivo autoxidation of dopamine in guinea pig striatum increases with age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Neurotoxicity of endogenous cysteinylcatechols

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Cell death induced by β-amyloid 1–40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Mitochondria and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Purification and characterization of cysteine-S-conjugate N-acetyltransferase from pig kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Role of dopamine in ischemic striatal injury: metabolic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Neuroprotection for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Effect of deprenyl on the progression of disability in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Possible role of neuromelanin in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Covalent crosslinking of neurofilament proteins by oxidized catechols as a potential mechanism of Lewy body formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Endogenous catechol thioethers may be pro-oxidant or antioxidant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Metabolism of 5-(glutathion-S-yl)-alpha-methyldopamine following intracerebroventricular administration to male Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Further insights into the influence of L-cysteine on the oxidation chemistry of dopamine: reaction pathways of potential relevance to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Brain mitochondria catalyze the oxidation of 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1) to intermediates that irreversibly inhibit complex I and scavenge glutathione: potential relevance to the pathogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1): a putative nigral endotoxin of relevance to Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100102339

21 January 2018

Identifiers

DOI

10.1081/DMR-100102339

1 reference

31 July 2017

1 reference